5 companies owned by Kenyan businessman John Kibunga Kimani
Billionaires.Africa has identified and tracked companies owned by Kimani.
Skip to content
Billionaires.Africa has identified and tracked companies owned by Kimani.
Anadkat presently owns an impressive 35.51-percent stake in FMB Capital, which translates to 872,924,575 ordinary shares.
Belinda Ajoke Disu, Adenuga’s daughter, serves on the board of Julius Berger, bringing a strong link between the telecom mogul and the group.
Before joining AngloGold Ashanti, Ramos was the CEO of Absa Group Limited, a key player in Africa’s financial services sector.
As a top shareholder in the Lagos-based lender, Femi Otedola stands to benefit from FBNH’s impressive financial performance.
The decline in Blair’s remuneration underscores the complex relationship between executive compensation and a company’s financial performance.
Coumantaros, ranked as one of the richest investors on the Nigerian Exchange, holds a 63.34 percent stake in Flour Mills of Nigeria.
Dangote Cement’s remarkable financial performance and ability to sustain profit growth solidify its position as a top player in the African cement industry.
In addition to his executive and governance responsibilities, Roy Bagattini holds a minority stake of 0.158 percent in Woolworths Holdings.
Berzi owns a significant 41.95-percent stake in the leading packaged food manufacturer through Quantum Invest BV.
Elumelu, through his investment firm HH Capital, holds a 29.5-percent stake in Transcorp, or 11,990,957,350 ordinary shares.
Attridge, Aspen’s group chief advisor, who ranks as one of South Africa’s richest businessmen, owns a 4.26-percent stake in the pharmaceutical holding company.
In 2012, Reffkin and Ori Allon founded Compass, Inc., an online real estate tech firm.
With a net worth of $3 billion, only five Black individuals globally surpass Jordan’s financial standing.
Darwish holds a substantial 4.17-percent stake in IHS Holdings, or 13,958,158 shares.
Saad, who founded Aspen in 1997, owns a 12.5-percent stake, or 57,151,972 ordinary shares, in the branded pharmaceutical holding company.